Propranolol HCl Tablets

Active Ingredients: Propranolol HCl

Propranolol HCl Tablets are used to treat certain heart-related conditions such as angina or heart-rhythm disorders. This medication may also be prescribed for hypertension and is used for migraine prevention. Other approved uses may vary according to the product registration and prescribing information in each market.

Propranolol is classified as a beta-blocker, also called a beta-adrenergic blocking agent. It works by blocking the effects of certain naturally occurring chemicals, including epinephrine, on beta-adrenergic receptors. This can reduce heart rate, blood pressure and the workload on the heart.

The 2026 AAN/AHS adult migraine-prevention guideline identifies propranolol as an evidence-supported preventive option for adults with episodic migraine. When evidence of efficacy is a priority, propranolol is included among treatments supported by high- or moderate-confidence evidence. The accompanying systematic review of pharmacologic migraine prevention, which included 217 studies, found moderate-confidence evidence supporting propranolol for reducing headache frequency in episodic migraine. Treatment choice should be individualized according to medical and psychiatric history, contraindications, adverse effects, other medications and patient preferences.

AdvaCare is a GMP-certified producer and supplier of Propranolol HCl Tablets. This medication is manufactured in our factories in China, India, and the USA. We routinely inspect our manufacturing facilities to ensure our products meet quality and safety standards.

AdvaCare Pharma is a manufacturer of Propranolol Tablets and other cost-effective and sustainable pharmaceuticals for an ever-changing global market. Propranolol Tablets are a GMP-compliant medicine that is available for distribution.

As a leading Propranolol manufacturer, we work with international partners including pharmaceutical distributors, hospitals, pharmacies and other medical and government organizations. We have established a vested supplier-distributor relationship, ensuring a mutually advantageous outcome during market entry and development.

What is Propranolol HCl used for?

Propranolol HCl is also used for migraine prevention. According to propranolol prescribing information, propranolol is used prophylactically and is not indicated to treat a migraine attack that has already started.

Other approved indications may vary according to local product registration and prescribing information.

How should Propranolol HCl Tablets be used?

This medication is intended to be taken orally.

What dose should be taken?

The appropriate dose of Propranolol HCl Tablets depends on the condition being treated, the patient's clinical status, response to treatment and the locally approved prescribing information.

Dosing differs across indications, so one dosage schedule should not be applied to every use. A doctor or pharmacist should determine the appropriate dose and duration of treatment.

When is preventive treatment for migraine considered?

The 2026 AAN/AHS guideline recommends offering preventive treatment to adults who experience at least 4 migraine days per month, at least 4 moderate-to-severe headache days per month, or substantial migraine-related disability.

The choice of preventive medication should be individualized according to medical history, contraindications, adverse effects, comorbidities, other medications and patient preferences.

As with all pharmaceuticals, some unwanted effects can occur from the use of Propranolol HCl Tablets.

For a comprehensive understanding of all potential side effects, consult a medical professional.

If any symptoms persist or worsen, or you notice any other symptoms, please call your doctor immediately.

Before treatment, consult your doctor regarding any medications you are taking to address potential drug interactions.

This medication may not be suitable for people with certain conditions, so it is important to consult with a doctor if you have any health conditions.

Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations

This joint practice guideline from the American Academy of Neurology (AAN) and American Headache Society (AHS) provides updated evidence-based recommendations for pharmacologic migraine prevention in adults.

The guideline recommends offering preventive treatment to adults with at least 4 migraine days per month, at least 4 moderate-to-severe headache days per month, or substantial migraine-related disability. For episodic migraine, propranolol is included among the preventive treatments clinicians should offer when evidence of efficacy is a priority. Treatment selection should account for patient history, contraindications, adverse effects, comorbidities and individual preferences.

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults

This systematic review was conducted to support the updated AAN/AHS recommendations on pharmacologic migraine prevention in adults.

A total of 217 studies met the review's inclusion criteria. For episodic migraine, the review found moderate-confidence evidence supporting propranolol for reducing headache frequency. Evidence directly comparing different preventive treatments was generally limited, so the findings should not be interpreted as showing that propranolol is superior to all other preventive therapies.

DailyMed — Propranolol Hydrochloride Tablets, USP

The U.S. prescribing information provides regulatory information on the indications, dosage, contraindications, warnings and adverse reactions associated with propranolol hydrochloride tablets.

The prescribing information identifies propranolol as a medicine used for migraine prophylaxis and states that its efficacy for treating a migraine attack that has already started has not been established. Approved indications and dosing should always be confirmed against the product information applicable to the destination market.